Your browser doesn't support javascript.
loading
Interim Analysis of a Prospective Validation of 2 Blood-Based Genomic Assessments (PPQ and NETest) to Determine the Clinical Efficacy of 177Lu-DOTATATE in Neuroendocrine Tumors.
Bodei, Lisa; Raj, Nitya; Do, Richard K; Mauguen, Audrey; Krebs, Simone; Reidy-Lagunes, Diane; Schöder, Heiko.
Afiliação
  • Bodei L; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; bodeil@mskcc.org.
  • Raj N; Department of Radiology, Weill Cornell Medical College, New York, New York.
  • Do RK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; and.
  • Mauguen A; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Krebs S; Department of Radiology, Weill Cornell Medical College, New York, New York.
  • Reidy-Lagunes D; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Schöder H; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
J Nucl Med ; 64(4): 567-573, 2023 04.
Article em En | MEDLINE | ID: mdl-36396457

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organometálicos / Tumores Neuroendócrinos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organometálicos / Tumores Neuroendócrinos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article